CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 674 enrolled
Drug / intervention
citalopramdrug
Likely dose
citalopram 60 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00369746
NCT00369746N/ACompleted
CompareCT.gov

Treatment of Depression Concurrent With Alcohol Abuse, an Extension of Alcohol Use Disorder in Patients Treated for Depression

New York State Psychiatric Institute·observational·Posted Aug 29, 2006·Updated May 9, 2014

In Brief

An observational study evaluating citalopram for Major Depressive Disorder and Alcohol Use Disorder. Completed, enrolled 674 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if having an alcohol use disorder affects recovery from depression, and also whether recovery from depression in patients who have alcohol use disorders is also accompanied by improvement in the alcohol use disorder.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder, Alcohol Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 29, 2006
Enrollment StartSep 1, 2006
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 19.8 years ago

Interventions

citalopramdrug

tablets, 60 mg maximum, daily, 12 weeks